减肥药迈入“吃药时代”?礼来口服神药试验成功,股价飙涨创25年新高!

金十数据
21 Apr

在公布一种用于2型糖尿病和肥胖治疗的GLP-1药物口服剂型的三期试验取得积极成果后,礼来(LLY.N)股价周四暴涨14%,创下近25年来最大单日涨幅。据道琼斯市场数据称,上一次股价涨幅如此之大还要追溯到2000年6月29日,当日收涨17.7%。过去五个交易日中,该股上涨了四天,目前在标普500指数中领涨。礼来表示,名为orforglipron的药物在三期临床试验中显示出具有统计学意义的积极效果,其...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10